Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $21.71M.
ENTERPRISE VALUE (EV)
$21.71M
Connect Biopharma Holdings Limited
Market Cap
$60.05M
Enterprise Value (EV)
$21.71M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $60.05M | $21.71M |
| Adicet Bio, Inc. (ACET)vs › | $60.11M | $39.83M |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.91M | $56.24M |
| Fractyl Health, Inc. (GUTS)vs › | $59.89M | $73.49M |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.49M | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.12M | $19.34M |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.99M | $50.18M |
| Boundless Bio, Inc. (BOLD)vs › | $57.42M | $37.21M |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | $67.02M |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A |
Market Cap
$60.05M
Total Debt
$0.00
Cash
$38.34M
Enterprise Value
$21.71M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
